新产业(300832) - 2024 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2024 was ¥1,021,430,174.73, representing a 16.62% increase compared to ¥875,859,175.30 in the same period last year[4] - Net profit attributable to shareholders was ¥426,221,043.84, up 20.04% from ¥355,067,920.04 year-on-year[4] - The total profit reached RMB 486.48 million, an increase of 19.97% compared to the same period last year[17] - Net profit attributable to shareholders was RMB 426.22 million, up 20.04% year-on-year[17] - Basic earnings per share for Q1 2024 were ¥0.5425, compared to ¥0.4522 in Q1 2023, indicating a growth of 20%[24] Cash Flow and Liquidity - The net cash flow from operating activities increased by 45.73% to ¥261,740,277.69, compared to ¥179,610,145.96 in the previous year[10] - The cash flow from operating activities was ¥926,490,723.18, up from ¥784,330,529.36 in the previous year, indicating a growth of 18.1%[26] - Cash and cash equivalents at the end of the period totaled CNY 1,027,068,268.06, compared to CNY 699,418,197.44 at the end of the previous period[28] - The company paid CNY 277,834,631.31 to employees, which is an increase of 21.4% compared to CNY 228,794,099.93 in the previous period[27] Assets and Liabilities - The total assets at the end of the reporting period were ¥8,574,960,297.26, a 4.29% increase from ¥8,222,488,843.69 at the end of the previous year[4] - Current liabilities decreased to ¥526,326,559.82 from ¥591,480,341.29, a reduction of 11%[21] - The company’s total liabilities decreased to ¥610,451,130.26 from ¥678,088,606.49, a decline of 10%[21] - The company's cash and cash equivalents at the end of Q1 2024 amounted to RMB 1,028.41 million, down from RMB 1,048.27 million at the beginning of the quarter[19] Revenue Breakdown - Domestic market revenue grew by 12.17%, while overseas market revenue increased by 24.95%[17] - The company reported a 26.42% increase in reagent revenue, while instrument product revenue declined by 3.86%[17] - Sales of the MAGLUMI X8 fully automated chemiluminescence instrument reached 220 units in Q1 2024[17] Expenses - Management expenses increased by 40.36% to ¥29,280,027.63, primarily due to higher employee compensation and depreciation[9] - The company reported a significant increase in research and development expenses, which amounted to ¥101,455,514.48 in Q1 2024, compared to ¥83,186,812.28 in Q1 2023, representing a growth of 22%[22] Investment Activities - Investment income rose by 49.27% to ¥18,188,377.43, attributed to changes in financial product returns[9] - Total cash inflow from investment activities was CNY 1,610,286,258.34, down 43.3% from CNY 2,840,462,613.25 in the prior period[27] - The net cash flow from investment activities was -CNY 277,676,044.43, a decrease from CNY 41,107,370.59 in the previous period[27] - The cash outflow for investment activities was CNY 1,887,962,302.77, a decrease from CNY 2,799,355,242.66 in the prior period[27] Other Financial Metrics - The weighted average return on equity rose to 5.49%, an increase of 0.09 percentage points from 5.40%[4] - The company experienced a 127.15% increase in credit impairment losses, amounting to -¥8,200,733.96, compared to -¥3,610,205.92 in the previous year[9] - The number of ordinary shareholders at the end of the reporting period was 16,458[11]